HPV-based cervical cancer screening using a Pap smear-free device for urine self-collection
Cervical cancer can be prevented through vaccination and screening; however, it remains the fourth most common cancer type in women, with over 500,000 cases detected in 2018. Most cases of cervical cancer have been linked to types of high-risk Human Papillomavirus (HPV), a common sexually transmitted infection.
Regular cytology-based screening for cervical cancer via a Pap smear, which looks for abnormal cervical cells, has directly shown to improve incidence and mortality rates. Despite the benefits, many women are often reluctant to undergo a Pap smear.
Download the white paper to learn how a new urine-collecting device will give doctors a user-friendly option for cervical cancer screening, from Novosanis.
